Australia markets closed

Alterity Therapeutics Limited (ATH.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.00700.0000 (0.00%)
At close: 12:33PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 17.08M
Enterprise value 1.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)735.64
Price/book (mrq)0.75
Enterprise value/revenue -1.77k
Enterprise value/EBITDA -0.11

Trading information

Stock price history

Beta (5Y monthly) 0.75
52-week change 3-50.00%
S&P500 52-week change 318.47%
52-week high 30.0140
52-week low 30.0060
50-day moving average 30.0070
200-day moving average 30.0078

Share statistics

Avg vol (3-month) 31.24M
Avg vol (10-day) 31.15M
Shares outstanding 52.44B
Implied shares outstanding 62.44B
Float 81.97B
% held by insiders 115.00%
% held by institutions 10.33%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)30 June 2023


Profit margin 0.00%
Operating margin (ttm)-373.72%

Management effectiveness

Return on assets (ttm)-26.64%
Return on equity (ttm)-47.38%

Income statement

Revenue (ttm)3.92M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-44.60%
Gross profit (ttm)3.63M
Net income avi to common (ttm)-13.81M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.77M
Total cash per share (mrq)0.01
Total debt (mrq)210.38k
Total debt/equity (mrq)0.92%
Current ratio (mrq)6.17
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-20.04M
Levered free cash flow (ttm)-14.53M